Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R.

Br J Psychiatry. 1999 Dec;175:576-80.

PMID:
10789357
2.

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.

Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D.

Br J Psychiatry. 1996 Oct;169(4):483-8.

PMID:
8894200
3.

Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.

Lau KL, Yim PH.

East Asian Arch Psychiatry. 2015 Dec;25(4):164-7.

4.

Haematological side effects of clozapine: patient characteristics.

Miller PR, Cutten AE.

N Z Med J. 1997 Apr 11;110(1041):125-7.

PMID:
9140414
5.

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.

Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.

BMC Psychiatry. 2016 Dec 12;16(1):441.

6.

Clozapine, agranulocytosis, and benign ethnic neutropenia.

Rajagopal S.

Postgrad Med J. 2005 Sep;81(959):545-6. No abstract available.

7.

Lithium and clozapine-induced neutropenia/agranulocytosis.

Blier P, Slater S, Measham T, Koch M, Wiviott G.

Int Clin Psychopharmacol. 1998 May;13(3):137-40.

PMID:
9690982
8.

Reversible neutropenia with olanzapine following clozapine-induced neutropenia.

Thangadurai P, Jyothi KS, Gopalakrishnan R, Kuruvilla A, Jacob KS.

Am J Psychiatry. 2006 Jul;163(7):1298. No abstract available.

PMID:
16816247
9.

A follow-up study of a population of schizophrenic patients treated with clozapine.

Bourin M, Guitton B, Dailly E, Hery P, Jolliet P.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 Nov;25(8):1481-95.

PMID:
11642649
10.

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients.

Valevski A, Klein T, Gazit E, Meged S, Stein D, Elizur A, Narinsky ER, Kutzuk D, Weizman A.

Eur J Immunogenet. 1998 Feb;25(1):11-3.

PMID:
9587740
11.

Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.

Vila-Rodriguez F, Tsang P, Barr AM.

Am J Psychiatry. 2013 Oct;170(10):1213-4. doi: 10.1176/appi.ajp.2013.13020215. No abstract available.

PMID:
24084822
12.

[A case study; ethnicity and clozapine, a risky combination?].

Laan WJ, Ramlal D.

Tijdschr Psychiatr. 2012;54(9):829-33. Dutch.

13.

Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.

Dunk LR, Annan LJ, Andrews CD.

Br J Psychiatry. 2006 Mar;188:255-63.

14.

Use of cytokines in clozapine-induced agranulocytosis.

Chin-Yee I, Bezchlibnyk-Butler K, Wong L.

Can J Psychiatry. 1996 Jun;41(5):280-4. Review.

PMID:
8793147
15.

The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.

Maskasame S, Krisanaprakornkit T, Khiewyoo J.

J Med Assoc Thai. 2007 Oct;90(10):2175-80.

PMID:
18041439
16.

A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.

Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.

J Clin Psychiatry. 2011 Dec;72(12):1659. doi: 10.4088/JCP.11cr07263. No abstract available.

PMID:
22244024
17.

Granulocytopenia with clozapine and quetiapine.

Diaz P, Hogan TP.

Am J Psychiatry. 2001 Apr;158(4):651. No abstract available.

PMID:
11282709
18.

[Reversible clozapine-induced agranulocytosis].

Nery-Fernandes F, Silveira VP, Quarantini LC, Coutinho DM, Scippa AM.

Rev Bras Psiquiatr. 2006 Jun;28(2):162. Epub 2006 Jun 26. Portuguese. No abstract available.

19.

Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012).

Balda MV, Garay OU, Papale RM, Bignone I, Bologna VG, Brandolini A, Prokopez CR, Balasini JI, Baldessarini RJ, Daray FM.

Int Clin Psychopharmacol. 2015 Mar;30(2):109-14. doi: 10.1097/YIC.0000000000000060.

PMID:
25486383
20.

Clozapine-induced agranulocytosis after 11 years of treatment.

Sedky K, Shaughnessy R, Hughes T, Lippmann S.

Am J Psychiatry. 2005 Apr;162(4):814. No abstract available.

PMID:
15800170

Supplemental Content

Support Center